NCT06418217 Exercise and Patient Education for Patients With Lateral Hip Pain
| NCT ID | NCT06418217 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jeppe Lange |
| Condition | Gluteal Tendinitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-05-17 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-05-17 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective cohort trial will investigate a progressive exercise protocol and patient education for patients with hip abductor tendon pathology. The primary outcome is patient reported pain measured by the revised Copenhagen Hip And Groin Outcome Score (HAGOS), that will be conducted at baseline and at a 12 week follow-up.
Eligibility Criteria
Inclusion Criteria: * Age 18-75 years * MRI verified HATP * Lateral hip pain duration \> 6 months * Ability to read and understand Danish. Exclusion Criteria: * Corticosteroid injection in the affected hip joint within the last six weeks prior to the intervention * Previous bone-related surgery to the affected hip, * Signs of bilateral HATP * X-ray verified hip osteoarthritis * Pregnancy
Contact & Investigator
Mathias Høgsholt, PT, PhD.st.
PRINCIPAL INVESTIGATOR
Horsens Regional Hospital; Aarhus University
Frequently Asked Questions
Who can join the NCT06418217 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Gluteal Tendinitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06418217 currently recruiting?
Yes, NCT06418217 is actively recruiting participants. Contact the research team at mathhg@rm.dk for enrollment information.
Where is the NCT06418217 trial being conducted?
This trial is being conducted at Horsens, Denmark.
Who is sponsoring the NCT06418217 clinical trial?
NCT06418217 is sponsored by Jeppe Lange. The principal investigator is Mathias Høgsholt, PT, PhD.st. at Horsens Regional Hospital; Aarhus University. The trial plans to enroll 60 participants.